{"id":"https://openalex.org/W4244895582","doi":"https://doi.org/10.1158/1538-7445.sabcs18-912","title":"Abstract 912: Macrophage inhibitory factor (MIF), osteopontin (OPN) and anti-interleukin-8 (IL-8) autoantibodies (AAb) complement CA125 for detection of early-stage ovarian cancer","display_name":"Abstract 912: Macrophage inhibitory factor (MIF), osteopontin (OPN) and anti-interleukin-8 (IL-8) autoantibodies (AAb) complement CA125 for detection of early-stage ovarian cancer","publication_year":2019,"publication_date":"2019-07-01","ids":{"openalex":"https://openalex.org/W4244895582","doi":"https://doi.org/10.1158/1538-7445.sabcs18-912"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs18-912","doi":"https://doi.org/10.1158/1538-7445.sabcs18-912","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs18-912","pdf_url":null,"source":{"id":"https://openalex.org/S4306506411","display_name":"Clinical Research (Excluding Clinical Trials)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Research (Excluding Clinical Trials)","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Jing Guo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jing Guo","raw_affiliation_strings":["UT MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UT MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004432933","display_name":"Wei\u2010Lei Yang","orcid":"https://orcid.org/0000-0001-6559-0556","observed_orcids":["https://orcid.org/0000-0001-6559-0556"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Wei-lei Yang","raw_affiliation_strings":["UT MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UT MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063539265","display_name":"Joseph Celestino","orcid":"https://orcid.org/0000-0002-7758-1558","observed_orcids":["https://orcid.org/0000-0002-7758-1558"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Joseph Celestino","raw_affiliation_strings":["UT MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UT MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078692182","display_name":"Karen H. Lu","orcid":"https://orcid.org/0000-0002-5317-9927","observed_orcids":["https://orcid.org/0000-0002-5317-9927"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen Lu","raw_affiliation_strings":["UT MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UT MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071827985","display_name":"Anna E Lokshin","orcid":"https://orcid.org/0000-0001-8171-220X","observed_orcids":["https://orcid.org/0000-0001-8171-220X"]},"institutions":[{"id":"https://openalex.org/I170201317","display_name":"University of Pittsburgh","ror":"https://ror.org/01an3r305","country_code":"US","type":"education","lineage":["https://openalex.org/I170201317"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anna E. Lokshin","raw_affiliation_strings":["University of Pittsburgh, PA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Pittsburgh, PA","institution_ids":["https://openalex.org/I170201317"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100388630","display_name":"Zhen Lu","orcid":"https://orcid.org/0000-0002-3481-6310","observed_orcids":["https://orcid.org/0000-0002-3481-6310"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zhen Lu","raw_affiliation_strings":["UT MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UT MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5067595997","display_name":"Robert C. Bast","orcid":"https://orcid.org/0000-0003-4621-8462","observed_orcids":["https://orcid.org/0000-0003-4621-8462"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Robert C. Bast","raw_affiliation_strings":["UT MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UT MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"912","last_page":"912"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9990000128746033,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10390","display_name":"Ovarian function and disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/macrophage-inhibitory-factor","display_name":"macrophage inhibitory factor","score":0.8450000286102295},{"id":"https://openalex.org/keywords/osteopontin","display_name":"osteopontin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/ca125","display_name":"CA125","score":0.9309999942779541},{"id":"https://openalex.org/keywords/early-stage-ovarian-cancer","display_name":"early-stage ovarian cancer","score":0.9259999990463257},{"id":"https://openalex.org/keywords/serum-biomarkers","display_name":"serum biomarkers","score":0.7200000286102295},{"id":"https://openalex.org/keywords/tumor-screening","display_name":"cancer screening","score":0.39500001072883606},{"id":"https://openalex.org/keywords/biomarker-panel","display_name":"biomarker panel","score":0.703000009059906},{"id":"https://openalex.org/keywords/sensitivity-and-specificity","display_name":"sensitivity and specificity","score":0.7229999899864197},{"id":"https://openalex.org/keywords/ovarian-cancer-detection","display_name":"ovarian cancer detection","score":0.40299999713897705},{"id":"https://openalex.org/keywords/interleukin-8","display_name":"interleukin-8","score":0.7519999742507935},{"id":"https://openalex.org/keywords/leptin","display_name":"leptin","score":0.5910000205039978},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.8899999856948853},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.718999981880188},{"id":"https://openalex.org/keywords/fibroblast-growth-factor-2","display_name":"fibroblast growth factor 2","score":0.7350000143051147},{"id":"https://openalex.org/keywords/he4","display_name":"HE4","score":0.9020000100135803}],"concepts":[{"id":"https://openalex.org/C104177226","wikidata":"https://www.wikidata.org/wiki/Q15311903","display_name":"Macrophage migration inhibitory factor","level":3,"score":0.8777621388435364},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7273848652839661},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.6973676085472107},{"id":"https://openalex.org/C2780804394","wikidata":"https://www.wikidata.org/wiki/Q411994","display_name":"Osteopontin","level":2,"score":0.6963504552841187},{"id":"https://openalex.org/C163764329","wikidata":"https://www.wikidata.org/wiki/Q785022","display_name":"Autoantibody","level":3,"score":0.6434045433998108},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.47103458642959595},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.446996808052063},{"id":"https://openalex.org/C146357865","wikidata":"https://www.wikidata.org/wiki/Q1123245","display_name":"Stage (stratigraphy)","level":2,"score":0.43601831793785095},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4221875071525574},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.36187222599983215},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.23174646496772766},{"id":"https://openalex.org/C2778690821","wikidata":"https://www.wikidata.org/wiki/Q212354","display_name":"Cytokine","level":2,"score":0.18934258818626404},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.13975393772125244},{"id":"https://openalex.org/C151730666","wikidata":"https://www.wikidata.org/wiki/Q7205","display_name":"Paleontology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs18-912","doi":"https://doi.org/10.1158/1538-7445.sabcs18-912","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs18-912","pdf_url":null,"source":{"id":"https://openalex.org/S4306506411","display_name":"Clinical Research (Excluding Clinical Trials)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Research (Excluding Clinical Trials)","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2941674179","https://openalex.org/W4390706040","https://openalex.org/W3194657205","https://openalex.org/W2391802754","https://openalex.org/W2887177328","https://openalex.org/W3121170825","https://openalex.org/W2792254469","https://openalex.org/W2987192857","https://openalex.org/W2567104746","https://openalex.org/W2768234754"],"abstract_inverted_index":{"Background:":[0],"Early":[1],"detection":[2,205,329],"of":[3,15,32,46,51,67,90,123,172,206,219,245,330,337],"ovarian":[4,16,92,163,189,289,332],"cancer":[5,17,93,164,190,290,333],"promises":[6],"to":[7,215,239,270,287],"reduce":[8],"mortality.":[9],"At":[10],"present,":[11],"only":[12],"20":[13],"percent":[14],"is":[18,25],"found":[19,26],"in":[20,27,88,131,181,200,283],"early":[21,35,96,158,182,207,263],"stage":[22,36,97,103,159,183,187,208,233,264],"(I-II).":[23],"CA125":[24,203,213,246,286,327],"sera":[28,89,155],"from":[29,109,156,210,237,268,292],"approximately":[30],"60%":[31],"patients":[33,94,100,133,165,191,230,291],"with":[34,43,95,101,154,193,202,212,231,241,247,255,285,295],"disease.":[37],"Greater":[38],"sensitivity":[39,235,261],"could":[40,280],"be":[41,281],"observed":[42],"a":[44,65,135,217],"panel":[45,50,66,153,218],"blood":[47],"tests.Methods:":[48],"A":[49],"10":[52],"antigen":[53],"biomarkers":[54,199],"(MIF,":[55],"Leptin,":[56],"IL-6,":[57],"IL-8,":[58],"TNFa,":[59],"OPN,":[60,144],"FGF2,":[61],"HE4,":[62],"TGFa":[63],"and":[64,105,145,160,166,176,185,223,250,277,321],"autoantibodies":[68,147,324],"(AAbs)":[69],"against":[70],"12":[71],"antigens":[72],"(IL-8,":[73],"MDM2,":[74],"c-myc,":[75],"PLAT,":[76],"EpCAM,":[77],"HOXA7,":[78],"ENO1,":[79],"PDI,":[80],"HSPA5,":[81],"HSPA8,":[82],"ANXA2,":[83],"Cathepsin":[84],"D)":[85],"were":[86,128,148,179],"analyzed":[87],"77":[91],"(I-II),":[98],"50":[99,161],"late":[102,162,186,232],"(III-IV),":[104],"216":[106],"healthy":[107,168,194],"women":[108],"the":[110,197,242,338],"Normal":[111],"Risk":[112],"Ovarian":[113],"Cancer":[114,342,356],"Screening":[115],"Study":[116],"(NROSS)":[117],"using":[118,134,150],"Luminex-based":[119],"immunoassays.":[120],"Serum":[121,170],"levels":[122],"serum":[124],"tumor":[125],"marker":[126],"CA-125":[127],"routinely":[129],"measured":[130],"all":[132],"Roche":[136],"assay.":[137],"The":[138],"most":[139],"promising":[140],"markers":[141],"(CA125,":[142],"MIF,":[143,174,221,248,275],"anti-IL-8":[146],"validated":[149],"an":[151,256],"independent":[152,257],"69":[157],"200":[167],"controls.Result:":[169],"level":[171],"CA125,":[173,220],"OPN":[175,222,249,276],"IL-8":[177,224,251],"AAb":[178,225,252,279],"elevated":[180],"(I-II)":[184],"(III-IV)":[188],"compared":[192],"controls.":[195],"Analyzing":[196],"positive":[198],"combination":[201,284],"increased":[204,236],"disease":[209,234,265],"62%":[211],"alone":[214],"92%":[216],"at":[226,272],"98%":[227,240,273],"specificity.":[228],"For":[229],"90%":[238],"panel.":[243],"Complementarity":[244],"was":[253,266],"confirmed":[254],"validation":[258],"set,":[259],"where":[260],"for":[262,328,341],"improved":[267],"84%":[269],"91%":[271],"specificity.Conclusion:":[274],"IL8":[278],"used":[282],"distinguish":[288],"health":[293],"controls":[294],"high":[296],"sensitivity.Citation":[297],"Format:":[298],"Jing":[299],"Guo,":[300],"Wei-lei":[301],"Yang,":[302],"Joseph":[303],"Celestino,":[304],"Karen":[305],"Lu,":[306,311],"Anna":[307],"E.":[308],"Lokshin,":[309],"Zhen":[310],"Robert":[312],"C.":[313],"Bast.":[314],"Macrophage":[315],"inhibitory":[316],"factor":[317],"(MIF),":[318],"osteopontin":[319],"(OPN)":[320],"anti-interleukin-8":[322],"(IL-8)":[323],"(AAb)":[325],"complement":[326],"early-stage":[331],"[abstract].":[334],"In:":[335],"Proceedings":[336],"American":[339],"Association":[340],"Research":[343],"Annual":[344],"Meeting":[345],"2019;":[346],"2019":[347],"Mar":[348],"29-Apr":[349],"3;":[350],"Atlanta,":[351],"GA.":[352],"Philadelphia":[353],"(PA):":[354],"AACR;":[355],"Res":[357],"2019;79(13":[358],"Suppl):Abstract":[359],"nr":[360],"912.":[361]},"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2022-05-12T00:00:00"}